<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Photoaging</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Photoaging</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Photoaging</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna L Chien, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sewon Kang, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Craig A Elmets, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 24, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H16665010"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Photoaging, also called extrinsic aging, is premature skin aging resulting from prolonged and repeated exposure to solar radiation [<a href="#rid1">1</a>]. The changes of photodamage are superimposed on the changes caused by chronologic aging (the so-called intrinsic or programmed aging) and are responsible for most of the age-associated features of skin appearance. Salient clinical features of photoaging include fine and coarse wrinkles, dyspigmentation, and loss of elasticity. (See  <a class="medical medical_review" href="/z/d/html/14605.html" rel="external">"Normal aging", section on 'Skin'</a>.)</p><p>Photodamage can be partially prevented and reversed with proper sun protection and various prescription medications. However, concerns about photoaging are primarily cosmetic and are influenced by geographic differences, culture, and personal values.</p><p>The pathogenesis, clinical features, and medical treatment of photoaging will be discussed here. Procedural techniques for the treatment of photoaging, including laser therapy, injection of soft tissue fillers, and botulinum toxin, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/13645.html" rel="external">"Nonablative skin resurfacing for skin rejuvenation"</a> and  <a class="medical medical_review" href="/z/d/html/13629.html" rel="external">"Ablative laser resurfacing for skin rejuvenation"</a> and  <a class="medical medical_review" href="/z/d/html/16532.html" rel="external">"Injectable soft tissue fillers: Overview of clinical use"</a> and  <a class="medical medical_review" href="/z/d/html/13643.html" rel="external">"Overview of botulinum toxin for cosmetic indications"</a>.)</p><p class="headingAnchor" id="H10962084"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span><span class="headingEndMark"> — </span>Photoaging is responsible for the majority of age-associated cosmetic skin problems in fair-skinned populations. In European and North American adult populations with skin phototypes I, II, and III  (<a class="graphic graphic_table graphicRef60541" href="/z/d/graphic/60541.html" rel="external">table 1</a>), the prevalence of clinically detectable photoaging may be as high as 80 to 90 percent [<a href="#rid2">2</a>].</p><p>Risk factors for photoaging include older age, male sex, skin phototypes I to III, high occupational or recreational sun exposure, and living in geographic locations with high sun irradiation [<a href="#rid3">3</a>]. Individuals with fair and less pigmented skin are at increased risk for photodamage and sun-induced skin cancer. The amount of time spent in the sunlight over a lifetime is a key risk factor for photoaging. (See  <a class="medical medical_review" href="/z/d/html/5335.html" rel="external">"Basal cell carcinoma: Epidemiology, pathogenesis, clinical features, and diagnosis", section on 'Risk factors'</a> and  <a class="medical medical_review" href="/z/d/html/5337.html" rel="external">"Cutaneous squamous cell carcinoma: Epidemiology and risk factors", section on 'Risk factors'</a> and  <a class="medical medical_review" href="/z/d/html/4844.html" rel="external">"Melanoma: Epidemiology and risk factors", section on 'Geographic and ethnic variation'</a>.)</p><p>In an Australian study, skin texture changes of moderate to severe photoaging were observed in 72 percent of men and 47 percent of women under the age of 30 [<a href="#rid4">4</a>]. The severity of photoaging increases rapidly after the age of 30 and is associated with medium or light skin color, burning and never tanning after exposure to strong sunlight, and prolonged occupational or recreational sun exposure [<a href="#rid3">3</a>].</p><p>In populations with darker skin, wrinkling is not readily apparent until the age of approximately 50 years, and the severity is not as marked as in light-skinned populations of similar age [<a href="#rid5">5</a>]. One study found that the onset of wrinkles in Chinese women occurred on average 10 years later than in French women [<a href="#rid6">6</a>]. However, in Chinese women, the appearance of hyperpigmented spots was an earlier and more prominent sign of photoaging than in French women.</p><p class="headingAnchor" id="H16665018"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The loss of the structural integrity of the dermal extracellular matrix caused by chronic ultraviolet (UV) exposure is believed to be primarily responsible for the wrinkled appearance of photodamaged skin [<a href="#rid7">7</a>]. The dermal extracellular matrix is a complex meshwork of several macromolecules, including collagen and elastic fibers, glycoproteins, and glycosaminoglycans, which provide strength and resilience to the skin. Type I and III collagens are the most abundant proteins in the dermis and the main target of sun-induced damage.</p><p class="headingAnchor" id="H3041232109"><span class="h2">Ultraviolet radiation</span><span class="headingEndMark"> — </span>Both ultraviolet A (UVA) and ultraviolet B (UVB) appear to be implicated in the photoaging process, although UVA is emerging as the major contributor to photodamage [<a href="#rid8">8</a>]. UVA (320 to 400 nm) is thought to have a larger role than UVB in photoaging because it is able to penetrate deeper into the dermis than UVB and is at least 10-fold more abundant than UVB in the terrestrial sunlight [<a href="#rid9">9</a>].</p><p>Short wave UVB (290 to 320 nm) are mainly absorbed in the epidermis by cellular DNA. They induce direct DNA damage with formation of cyclobutane pyrimidine dimers and 6,4-photoproducts and are responsible for sunburn, inflammation, photocarcinogenesis, and immunosuppression [<a href="#rid10">10,11</a>]. UV radiation also indirectly damages DNA. The absorption of UVA photons transfers electrons and energy from cellular chromophores, such as porphyrins, bilirubin, melanin, and pterins, to oxygen molecules, resulting in the formation of singlet oxygen. Long wavelength radiations in the infrared (IR) range, which represent 50 percent of the total solar energy, may also contribute to photoaging of human skin [<a href="#rid12">12-14</a>].</p><p>The mechanisms underlying the UV-mediated damage to the skin connective tissue involve the formation of reactive oxygen species (ROS), cell surface receptor-initiated signaling, protein oxidation, and mitochondrial damage [<a href="#rid9">9,15</a>]. ROS, including superoxide anion, hydrogen peroxide, and singlet oxygen, activate cell surface receptors for cytokines and growth factors, including epidermal growth factor (EGF), interleukin (IL)-1, and tumor necrosis factor (TNF)-alpha. ROS also induce the transcription factor activator protein-1 (AP-1) and the nuclear transcription factor NF-kappa-B  (<a class="graphic graphic_figure graphicRef78164" href="/z/d/graphic/78164.html" rel="external">figure 1</a>).</p><p>AP-1 upregulates matrix metalloproteinases (MMPs), including interstitial collagenase (MMP-1), stromelysin-1 (MMP-3), and 92kDa gelatinase (MMP-9) [<a href="#rid15">15,16</a>]. The combined actions of MMP-1, MMP-3, and MMP-9 degrade most of type I and III dermal collagen. With repeated sun exposure, the degraded collagen accumulates over time, resulting in the clinical and histologic features of photoaging [<a href="#rid17">17-19</a>]. AP-1 also inhibits type I and type III procollagen gene expression in the dermis by binding to the transcriptional complex responsible for procollagen transcription or blocking the activity of transforming growth factor (TGF)-beta [<a href="#rid20">20,21</a>].</p><p>The activation of the nuclear transcription factor NF-kappa-B upregulates the expression of proinflammatory cytokines, such as IL-1-beta, TNF-alpha, IL-6, IL-8, and various adhesion molecules [<a href="#rid22">22,23</a>]. These cytokines in turn upregulate AP-1 and further activate the NF-kappa-B pathway, enhancing the response to UV irradiation.</p><p>Mitochondria are the main endogenous source of ROS, which are produced during the conversion of adenosine diphosphate (ADP) to adenosine triphosphate (ATP) [<a href="#rid9">9</a>]. Endogenous ROS, particularly singlet oxygen, may induce deletions and rearrangements of mitochondrial DNA (tDNA). The most common mitochondrial mutation is a 4977 base-pair deletion termed "common deletion," which is found with high frequency in degenerative diseases and cancer [<a href="#rid24">24,25</a>]. This mutation is increased in photodamaged skin and may be induced in dermal fibroblasts by repetitive exposure to UVA radiation. [<a href="#rid26">26,27</a>]. Furthermore, it has also been observed that large blocks of genomic hypomethylation occur in photoaged skin similar to those seen in cutaneous carcinogenesis [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H1500780202"><span class="h2">Visible light</span><span class="headingEndMark"> — </span>More recent data suggest that visible light (400 to 760 nm) also plays a role in photoaging. Visible light comprises at least 40 percent of solar irradiation and has deeper penetration into the skin, given its longer wavelength, than UV radiation. Similar to UV radiation, visible light has been shown to lead to the production of ROS, proinflammatory cytokines, and MMPs in the dermal matrix [<a href="#rid29">29,30</a>].</p><p>Interestingly, melanin has a peak absorption spanning part of the visible light spectrum. While increased melanin protects patients against UV radiation, it may enhance the deleterious effects of visible light, especially in individuals with skin of color [<a href="#rid31">31</a>]. One study demonstrated that visible light produced a more intense and sustained pigmentary response in more highly pigmented skin (skin phototypes IV to VI) compared with UVA radiation [<a href="#rid32">32</a>]. Furthermore, the authors found that visible light had minimal effects in less pigmented skin.</p><p>Pigmentation caused by visible light is believed to be mediated by the activation of opsin, a G protein-coupled receptor. Shorter wavelengths of visible light (ie, blue light) can activate opsin, which leads to an influx of calcium and induction of melanogenesis in melanocytes [<a href="#rid33">33</a>]. Additionally, in individuals with highly pigmented skin, persistent pigmentation after exposure to visible light is attributed to continued tyrosinase activation as a downstream effect of this pathway.</p><p class="headingAnchor" id="H908426476"><span class="h2">Other environmental factors</span><span class="headingEndMark"> — </span>In addition to sun exposure, several environmental factors may contribute to premature aging of the skin [<a href="#rid34">34</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Air pollution</strong> – There is growing evidence that exposure to indoor and outdoor air pollutants, including lead, particulate matter (soot, exhaust, industry), nitrogen oxide (car exhaust), sulphur oxide (industrial plants), and ozone (ground level), may contribute to skin aging [<a href="#rid34">34-40</a>]. The association between air pollution and premature skin aging is supported by several epidemiologic studies [<a href="#rid36">36,40</a>]. In vitro studies suggest that the ozone-induced activation of aryl hydrocarbon receptor (AhR) and cytochrome P450 may lead to the production of metabolites of air pollutants that are toxic to the skin [<a href="#rid34">34,41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tobacco smoke</strong> – The role of smoking in accelerating skin aging is corroborated by observational and epidemiologic studies [<a href="#rid3">3,42-44</a>]. The so-called "smoker's face" is characterized by prominent perioral and periocular wrinkles and uneven complexion with a grayish hue [<a href="#rid44">44</a>]. The mechanism of tobacco smoke leading to facial wrinkling is poorly understood but is thought to involve impaired collagen biosynthesis and collagen degradation through induction of MMPs [<a href="#rid45">45</a>].</p><p></p><p class="headingAnchor" id="H5836769"><span class="h1">HISTOPATHOLOGY</span><span class="headingEndMark"> — </span>Microscopic changes in the photodamaged skin include epidermal atrophy with thinning of the spinous layer, flattened dermoepidermal junction with loss of rete ridges, decreased collagen content, and deposition of amorphous masses of abnormally thickened, curled, and disintegrated elastic fibers and collagen breakdown products (solar elastosis)  (<a class="graphic graphic_picture graphicRef83455" href="/z/d/graphic/83455.html" rel="external">picture 1</a>). Increased number of atypical melanocytes and atypical epidermal cells may also be seen.</p><p class="headingAnchor" id="H16665025"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Sun-induced cutaneous changes vary among individuals, reflecting intrinsic differences in vulnerability and repair capacity. Age, sex, geographic location, and skin type  (<a class="graphic graphic_table graphicRef60541" href="/z/d/graphic/60541.html" rel="external">table 1</a>) are factors influencing the severity and clinical appearance of photoaging [<a href="#rid46">46</a>]. (See <a class="local">'Epidemiology and risk factors'</a> above.)</p><p class="headingAnchor" id="H3464913917"><span class="h2">Photoaging in individuals with phototypes I to IV</span><span class="headingEndMark"> — </span>In individuals with light phototypes  (<a class="graphic graphic_table graphicRef60541" href="/z/d/graphic/60541.html" rel="external">table 1</a>), sun-induced changes include fine and coarse wrinkles, solar elastosis, lentigines, mottled pigmentation, actinic keratoses, telangiectasias, loss of translucency and elasticity, xerotic texture, and sallow color  (<a class="graphic graphic_table graphicRef82638" href="/z/d/graphic/82638.html" rel="external">table 2</a> and <a class="graphic graphic_picture graphicRef81287 graphicRef61033 graphicRef68136 graphicRef71483 graphicRef53576 graphicRef66252" href="/z/d/graphic/81287.html" rel="external">picture 2A-F</a>) [<a href="#rid47">47,48</a>]. In particular:</p><p class="bulletIndent1"><span class="glyph">●</span>In populations with skin types I or II, atrophic and dysplastic changes (eg, actinic keratoses) with fine wrinkling are common signs of photoaging.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, in individuals with skin types III or IV, predominant features include increased skin thickness, deep wrinkles, and leathery appearance [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperpigmented macules and mottled hyperpigmentation are also common features of photodamaged skin  (<a class="graphic graphic_picture graphicRef81287" href="/z/d/graphic/81287.html" rel="external">picture 2A</a>) in phototypes I to IV [<a href="#rid49">49</a>].</p><p></p><p>In a study comparing age-matched Chinese women with White French women with similar lifelong sun exposure, although wrinkle onset occurred 10 years later in Chinese women, they had a higher prevalence and earlier appearance of hyperpigmented spots compared with French women [<a href="#rid6">6</a>]. Similar results were found in another study comparing skin aging features in German, Japanese, and Chinese women [<a href="#rid50">50</a>].</p><p>Other signs of severe photodamage include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Actinic purpura</strong> – Actinic purpura, also called senile purpura or Bateman purpura  (<a class="graphic graphic_picture graphicRef113703" href="/z/d/graphic/113703.html" rel="external">picture 3</a>), is a relatively common finding in older individuals with a history of excessive sun exposure. It presents as ecchymotic macules predominantly located on the photodamaged skin of forearms and dorsa of the hands.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Actinic elastosis and cutis rhomboidalis nuchae</strong> – Actinic elastosis presents as a diffuse thickening and yellowish discoloration of the skin resulting from disorganized and damaged collagen and elastic tissue. It is typically seen in older individuals with fair complexion and a history of chronic sun exposure. On the posterior aspect of the neck, the formation of deep furrows results in a typical, irregular, rhomboidal pattern (cutis rhomboidalis nuchae)  (<a class="graphic graphic_picture graphicRef119336" href="/z/d/graphic/119336.html" rel="external">picture 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Poikiloderma of Civatte</strong> – Poikiloderma of Civatte presents as mottled pigmentation and telangiectasias involving the lateral aspects of the neck and the upper anterior chest in fair-skinned individuals with a history of high cumulative sun exposure  (<a class="graphic graphic_picture graphicRef81779" href="/z/d/graphic/81779.html" rel="external">picture 5</a>). The submental area is typically spared. (See  <a class="medical medical_review" href="/z/d/html/89268.html" rel="external">"Acquired hyperpigmentation disorders", section on 'Poikiloderma of Civatte'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Favre-Racouchot syndrome</strong> – Favre-Racouchot syndrome is characterized by the development of multiple comedones on the periorbital area on a background of severely photodamaged skin  (<a class="graphic graphic_picture graphicRef59339" href="/z/d/graphic/59339.html" rel="external">picture 6</a>) [<a href="#rid51">51</a>]. It is most commonly seen in older males with light complexion and a history of chronic sun exposure. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic guttate hypomelanosis</strong> – Idiopathic guttate hypomelanosis presents as multiple small, white macules that are typically located on the extensor surfaces of the upper and lower extremities  (<a class="graphic graphic_picture graphicRef67346 graphicRef108026" href="/z/d/graphic/67346.html" rel="external">picture 7A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/103736.html" rel="external">"Acquired hypopigmentation disorders other than vitiligo", section on 'Idiopathic guttate hypomelanosis'</a>.)</p><p></p><p class="headingAnchor" id="H1751152420"><span class="h2">Photoaging in individuals with phototypes V to VI</span><span class="headingEndMark"> — </span>In individuals with skin types V or VI, the effects of photodamage generally occur 10 to 20 years later and are less severe than those observed in individuals with lighter skin, due to a lower susceptibility to sun damage [<a href="#rid52">52</a>]. In individuals with heavily pigmented skin, melanosomes are increased in number and size, contain more melanin, are more widely distributed in the epidermis, and are more slowly degraded, compared with lightly pigmented skin, leading to greater photoprotection [<a href="#rid53">53</a>].</p><p>In darker skin, premature aging typically manifests in the midface with prominent nasolabial folds, due to increased skin laxity, but fewer wrinkles  (<a class="graphic graphic_picture graphicRef119904" href="/z/d/graphic/119904.html" rel="external">picture 8</a>) [<a href="#rid53">53</a>]. Dyschromias can also be a prominent feature in these patients. Other signs may include mottled pigmentation, rough skin, dermatosis papulosa nigra, seborrheic keratoses, and solar lentigines.</p><p>While ultraviolet (UV) exposure is a major determinant of skin aging in individuals with light skin tones, its role is limited in those with highly pigmented skin. One study evaluated the correlation between photoaging scores and clinical, demographic, and lifestyle characteristics in 75 African American participants using a 9-point photonumeric scale designed to assess the degree of photodamage in highly pigmented skin [<a href="#rid53">53</a>]. In this study, only age was significantly correlated with skin aging; in a multiple regression model, sun exposure and male sex were contributor factors to skin aging.</p><p class="headingAnchor" id="H11306635"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of photoaging is clinical. Typical skin changes include fine and coarse wrinkles, lentigines, mottled pigmentation, loss of translucency and elasticity, and sallow color  (<a class="graphic graphic_picture graphicRef81287 graphicRef61033 graphicRef68136 graphicRef71483 graphicRef53576 graphicRef66252" href="/z/d/graphic/81287.html" rel="external">picture 2A-F</a>). In clinical practice, photographic scales of photoaging severity may be used for patient evaluation and management decisions  (<a class="graphic graphic_picture graphicRef68754" href="/z/d/graphic/68754.html" rel="external">picture 9</a>) [<a href="#rid54">54,55</a>]. A photonumeric scale for dark skin types has also been developed [<a href="#rid56">56</a>].</p><p>In research settings, several invasive and noninvasive methods have been used to quantify photodamage, including histopathology and immunohistochemistry, skin surface topography, ultrasound, or reflectance confocal microscopy [<a href="#rid57">57</a>].</p><p class="headingAnchor" id="H2919971050"><span class="h1">PREVENTION</span></p><p class="headingAnchor" id="H443808160"><span class="h2">Photoprotection</span><span class="headingEndMark"> — </span>Protection from the sun, including sun avoidance and use of sunscreens and protective clothing, is the first line of defense against photoaging for all skin types [<a href="#rid58">58</a>]. Ultraviolet (UV) irradiation tends to be the strongest at peak hours (10 AM to 4 PM) during summer months and at high altitudes [<a href="#rid59">59,60</a>]. Water, snow, and concrete can reflect up to 90 percent of the UV rays, whereas shade decreases the amount of UV by 50 to 90 percent [<a href="#rid61">61,62</a>]. Staying away from the sun in the peak hours or seeking shade may considerably reduce sun exposure.</p><p>We suggest daily use of broad-spectrum sunscreens, which provide protection against ultraviolet A (UVA) and ultraviolet B (UVB) radiation  (<a class="graphic graphic_table graphicRef73127" href="/z/d/graphic/73127.html" rel="external">table 3</a>), to prevent premature aging of the skin. Sunscreen use is especially important for individuals with light skin (phototypes I, II, and III) who live in areas with high levels of solar irradiation. It is important to note that most people do not apply an adequate amount of sunscreen. Using a broad-spectrum sunscreen with a sun protection factor (SPF) of 30 or greater or applying a lower SPF sunscreen twice may ensure proper protection (see  <a class="medical medical_review" href="/z/d/html/13751.html" rel="external">"Selection of sunscreen and sun-protective measures", section on 'Proper use of sunscreens'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized, community-based trial in Nambour, Australia, participants &lt;55 years were randomly assigned to daily use of broad-spectrum sunscreen with SPF of 15+ and 30 mg of <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">beta-carotene</a>, daily use of sunscreen and placebo, discretionary use of sunscreen and 30 mg of beta-carotene, and discretionary use of sunscreen and placebo [<a href="#rid63">63</a>]. Participants in the daily sunscreen group were instructed to apply sunscreen to their head, neck, arms, and hands every morning, with reapplication after heavy sweating, bathing, or spending more than a few hours outdoors. To assess photoaging, silicone impressions of the skin surface markings were obtained from the back of the left hand at baseline and at the end of the study and graded on a scale ranging from 0 to 6. After 4.5 years, participants in the daily sunscreen group, with or without supplementation with beta-carotene, were less likely to have an increase in photoaging grade than participants in the discretionary sunscreen group (odds ratio 0.76, 95% CI 0.50-0.98). Although this trial suggests that daily use of sunscreen slows photoaging in young or middle-aged individuals, its results may not be generalizable to populations different from the one in which it was conducted or living in other geographic areas.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective study, 32 women aged 40 to 55 years with Fitzpatrick phototype I to III applied a broad-spectrum, photostable sunscreen with SPF 30 daily for 52 weeks [<a href="#rid64">64</a>]. The comparison of paired digital photographs taken at baseline and at one year showed improvement in all parameters of photodamage, including overall facial photodamage score, crow's feet coarse wrinkles, and mottled pigmentation.</p><p></p><p>In addition to sunscreens, clothes, hats, and sunglasses provide uniform and reliable protection against UVB and UVA and are easy to use [<a href="#rid65">65,66</a>]. Factors that increase the ultraviolet protection factor (UPF) in clothing include synthetic (eg, polyester), tightly woven, thicker fabric, darker colors, and washing with optical whitening agents or UV-absorbing chemicals [<a href="#rid66">66-69</a>]. (See  <a class="medical medical_review" href="/z/d/html/13751.html" rel="external">"Selection of sunscreen and sun-protective measures"</a>.)</p><p>It is important to emphasize the importance of photoprotection for all skin types [<a href="#rid58">58</a>]. It is well established that individuals with skin type V to VI exhibit clinical and histologic evidence of photodamage, making photoprotection also a priority in this group. However, a common misconception is that persons with highly pigmented skin are not at risk for sun-related damage [<a href="#rid70">70</a>]. Thus, clinicians may be less likely to provide this form of education to this patient population. In a survey of dermatologists, 89 percent of participants reported discussing photoprotection with skin type I patients but only 28 percent reported the same counseling for skin type VI patients [<a href="#rid71">71</a>]. Furthermore, a population-based study found that only 31 percent of African Americans engaged in sun-protective behavior and up to 63 percent had never used sunscreen [<a href="#rid72">72</a>].</p><p>Strict sun protection may increase the risk for vitamin D deficiency [<a href="#rid73">73</a>], but most individuals do not apply sufficient amounts of sunscreen for this to be a significant problem [<a href="#rid74">74</a>]. However, oral vitamin D supplementation is a safe, well-tolerated, and inexpensive alternative to achieve adequate vitamin D levels [<a href="#rid75">75</a>]. (See  <a class="medical medical_review" href="/z/d/html/2022.html" rel="external">"Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment"</a> and  <a class="medical medical_review" href="/z/d/html/14590.html" rel="external">"Vitamin D insufficiency and deficiency in children and adolescents"</a>.)</p><p class="headingAnchor" id="H7498788"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H1362011327"><span class="h2">Overview</span><span class="headingEndMark"> — </span>Photoaging can be partially prevented and improved through a number of modalities, such as sun protection, topical prescription medications, cosmeceuticals, and cosmetic procedures. Factors to consider in the management of a patient with photoaging include the severity of skin changes and the patient's concern, expectations, and willingness to accept the costs of treatment:</p><p class="bulletIndent1"><span class="glyph">●</span>The first step in the management of photoaging involves educating the patient to adopt appropriate year-round sun protection measures, including sun avoidance, regular use of sunscreen and protective clothing, seeking shade, and avoiding peak sun hours. (See <a class="local">'Photoprotection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Topical retinoids are the mainstay of medical therapy for patients with mild to severe photoaging. The use of a topical retinoid should be tailored to the patient's skin type and ability to tolerate the medication. (See <a class="local">'First-line therapy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with actinic keratoses, photoaging may improve in response to treatment with topical <a class="drug drug_general" data-topicid="8464" href="/z/d/drug information/8464.html" rel="external">fluorouracil</a>. (See <a class="local">'Topical fluorouracil'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the patient is interested in pursuing additional therapies, options such as chemical peels, injectables, lasers, and photodynamic therapy and their potential adverse effects should be fully discussed with the patient. (See <a class="local">'Other therapeutic options'</a> below.)</p><p></p><p>A variety of other substances called cosmeceuticals, which include antioxidants, vitamins, or plant extracts, are incorporated in cosmetic preparations and have been used in conjunction with topical retinoids  (<a class="graphic graphic_table graphicRef83291" href="/z/d/graphic/83291.html" rel="external">table 4</a>). However, there is limited evidence from clinical studies to suggest that they are beneficial or that one particular preparation is better than another. (See <a class="local">'Cosmeceuticals'</a> below.)</p><p class="headingAnchor" id="H4057564413"><span class="h2">First-line therapy</span></p><p class="headingAnchor" id="H2333707197"><span class="h3">Topical retinoids</span><span class="headingEndMark"> — </span>Topical retinoids are the first-line therapy for photoaging. Retinoids are a class of naturally occurring or synthetic compounds related to retinol (<a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>). Retinoids exert their effects by binding and activating two groups of receptors belonging to the nuclear hormone receptor superfamily: the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs), which are ligand-dependent nuclear transcription factors [<a href="#rid76">76</a>]. In human skin, topical retinoids increase collagen production, induce epidermal hyperplasia, and decrease keratinocyte and melanocyte atypia [<a href="#rid77">77-81</a>].</p><p>Topical retinoids used for the treatment of photoaging include tretinoin (all-trans retinoic acid), <a class="drug drug_general" data-topicid="9665" href="/z/d/drug information/9665.html" rel="external">tazarotene</a> (a synthetic retinoid), and <a class="drug drug_general" data-topicid="9352" href="/z/d/drug information/9352.html" rel="external">adapalene</a> (a third-generation synthetic retinoid)  (<a class="graphic graphic_table graphicRef70303" href="/z/d/graphic/70303.html" rel="external">table 5</a>). Tretinoin is the most extensively investigated therapy for photoaging [<a href="#rid82">82</a>].</p><p class="headingAnchor" id="H89823566"><span class="h4">Pretreatment counseling</span><span class="headingEndMark"> — </span>It is important to counsel patients before initiating treatment with topical retinoids. Patients should be informed that local skin irritation can be expected as part of the treatment. Skin irritation, redness, scaling, dryness, burning, stinging, and peeling are common side effects of topical retinoids and often result in patient nonadherence [<a href="#rid83">83</a>]. Adverse effects peak during the first two weeks, are more frequent with higher concentrations, and decrease with time. Regular application of moisturizers is helpful in reducing irritation from topical retinoids.</p><p>Treatment with topical retinoids should not be started or continued during pregnancy because retinoids are known teratogens. However, there is no direct evidence that topical retinoids cause congenital malformations [<a href="#rid84">84,85</a>].</p><p class="headingAnchor" id="H1716379479"><span class="h4">Tretinoin</span><span class="headingEndMark"> — </span>We suggest <a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">topical tretinoin</a>  (<a class="graphic graphic_table graphicRef70303" href="/z/d/graphic/70303.html" rel="external">table 5</a>) as the initial treatment for photoaging. We prefer topical tretinoin to <a class="drug drug_general" data-topicid="9665" href="/z/d/drug information/9665.html" rel="external">tazarotene</a> because multiple available concentrations make titration easier, and in clinical experience (although not in clinical trials), tretinoin is less irritating than tazarotene.</p><p><a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">Topical tretinoin</a> can be used for mild to severe photoaging in patients of all skin prototypes. Several weeks or months of treatment typically are required before clinical improvement is appreciated [<a href="#rid77">77,86</a>].</p><p>The use of <a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">topical tretinoin</a> for the treatment of photoaging is supported by several randomized trials and one meta-analysis [<a href="#rid77">77,83,86-88</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 12 randomized trials demonstrated that in individuals with mild to severe photoaging of the face or forearms, tretinoin cream in concentrations of 0.02% to 0.1% applied once daily for 16 to 48 weeks was more effective than placebo in the physician-assessed overall improvement of photodamage [<a href="#rid83">83</a>]. As an example, the relative risk of overall improvement for tretinoin 0.05% cream versus placebo after 24 weeks was 1.73 (95% CI 1.39-2.14).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent trial evaluated the long-term efficacy and safety of daily application of tretinoin 0.05% cream for two years in 204 subjects with moderate to severe photoaging [<a href="#rid88">88</a>]. The improvement in all signs of photodamage, overall photodamage severity, and global assessment of clinical response was greater in the active treatment group than in the placebo group  (<a class="graphic graphic_picture graphicRef53021" href="/z/d/graphic/53021.html" rel="external">picture 10</a>). Treatment with tretinoin was not associated with increased keratinocytic or melanocytic atypia.</p><p></p><p class="headingAnchor" id="H2620795444"><span class="h5">Instructions for application</span><span class="headingEndMark"> — </span>The concentration and frequency of application of <a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">topical tretinoin</a> is titrated based upon the observed skin reaction in individual patients:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">Topical tretinoin</a> should be applied sparingly (eg, thin layer or pea-sized amount).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">Topical tretinoin</a> is initiated at the lowest active dose to minimize adverse effects and increase patient adherence. Topical tretinoin 0.02% or 0.025% cream or gel applied every other day, preferably at nighttime, is a common starting regimen. Patients with particularly sensitive skin may start with a twice-a-week regimen for the first few weeks and increase the frequency of application gradually.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">Topical tretinoin</a> concentration and frequency of application may be gradually increased over several weeks as tolerated by the patient, up to a daily application of topical tretinoin 0.1%. However, higher concentrations may not correlate with increased clinical efficacy. As an example, 0.1% topical tretinoin is considerably more irritating than 0.025% topical tretinoin but may not offer additional benefit [<a href="#rid87">87</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">Topical tretinoin</a> should be tried for a minimum of four months because benefits may not be appreciated before then [<a href="#rid83">83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The benefits of <a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">topical tretinoin</a> are lost upon discontinuation. Although it has only been studied for a duration of two years [<a href="#rid88">88</a>], it may be continued indefinitely. A long-term maintenance regimen with a lower concentration or less frequent application may be an alternative to continued use.</p><p></p><p class="headingAnchor" id="H3968056354"><span class="h4">Other topical retinoids</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tazarotene</strong> – <a class="drug drug_general" data-topicid="9665" href="/z/d/drug information/9665.html" rel="external">Tazarotene</a> is an alternative to tretinoin for patients with mild to severe photoaging who desire treatment  (<a class="graphic graphic_table graphicRef70303" href="/z/d/graphic/70303.html" rel="external">table 5</a>). Tazarotene is reserved for patients who have tolerated the highest concentration of tretinoin. It is also useful in patients who present with overactive sebaceous activity and oily skin complexion.</p><p></p><p class="bulletIndent1">The efficacy of topical <a class="drug drug_general" data-topicid="9665" href="/z/d/drug information/9665.html" rel="external">tazarotene</a> is supported by several randomized trials and a meta-analysis [<a href="#rid83">83,86,89</a>]. In individuals with mild to severe photoaging of the face, tazarotene 0.05% or 0.1% cream applied daily for 24 weeks was more effective than placebo in the physician-assessed overall improvement of photodamage [<a href="#rid83">83</a>]. In one small study, tazarotene 0.05% and 0.1% were as effective as tretinoin 0.05% [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adapalene</strong> – <a class="drug drug_general" data-topicid="9352" href="/z/d/drug information/9352.html" rel="external">Adapalene</a> is a third-generation, synthetic topical retinoid that shows selectivity for the nuclear RAR beta-gamma. Due to its receptor selectivity, it causes less skin irritation and can be used off-label for the treatment of photoaging in individuals with more sensitive skin. The efficacy of adapalene gel 0.1% or 0.3% for cutaneous photoaging has been evaluated in one randomized trial and in a few uncontrolled studies [<a href="#rid90">90,91</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a randomized trial designed to evaluate the efficacy of <a class="drug drug_general" data-topicid="9352" href="/z/d/drug information/9352.html" rel="external">adapalene</a> 0.1% or 0.3% gel for the treatment of actinic keratoses and solar lentigines in 90 participants (mean age 63 years), a blind examination of paired clinical photographs (before and after nine-month treatment) of 42 patients revealed an improvement in fine wrinkles and mottled pigmentation with adapalene in comparison with vehicle treatment [<a href="#rid90">90</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a six-month open-label study, 40 Latin American women with signs of facial photoaging were treated with <a class="drug drug_general" data-topicid="9352" href="/z/d/drug information/9352.html" rel="external">adapalene</a> 0.3% gel for 24 weeks [<a href="#rid91">91</a>]. Compared with baseline, improvements were noted in clinical grading of forehead, periorbital, and perioral wrinkles. Skin hydration and general skin tone were also improved.</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9352" href="/z/d/drug information/9352.html" rel="external">Adapalene</a> is US Food and Drug Administration (FDA) approved for the treatment of acne. In the United States, adapalene 0.1% gel is available without a prescription.</p><p></p><p class="headingAnchor" id="H346066976"><span class="h2">Complementary therapies</span></p><p class="headingAnchor" id="H1820534122"><span class="h3">Cosmeceuticals</span><span class="headingEndMark"> — </span>The term "cosmeceuticals" refers to a heterogeneous category of nonprescription topical products, including antioxidants, vitamins, retinoids, hydroxyacids, and plant extracts, that may have some activity in the treatment of photoaging  (<a class="graphic graphic_table graphicRef83291" href="/z/d/graphic/83291.html" rel="external">table 4</a>) [<a href="#rid92">92</a>]. However, since cosmeceuticals are not classified as drugs, they are not subject to rigorous testing or regulation by local regulatory agencies, such as the FDA in the United States or the European Medicines Agency.</p><p>Cosmeceuticals are popular ingredients of a wide range of cosmetic products and are sometimes used in conjunction with topical retinoids to potentially enhance the antiaging benefits. However, there is limited evidence from clinical studies to suggest that they are beneficial or that one particular preparation is better than another. In a small randomized study, nonprescription 1% topical retinol was as effective as 0.02% tretinoin in improving photoaging [<a href="#rid93">93</a>].</p><p class="headingAnchor" id="H1477721042"><span class="h2">Other therapeutic options</span><span class="headingEndMark"> — </span>Other treatments that have been used to improve the signs of photoaging are briefly discussed below. The decision to use these therapies in the treatment of photoaging depends upon individual patient values and preferences.</p><p class="headingAnchor" id="H16665060"><span class="h3">Chemical peels</span><span class="headingEndMark"> — </span>Chemical peels involve the application of caustic chemical substances to ablate definite skin layers; the subsequent cutaneous regeneration tightens the skin and evens the color. The decision to use chemical peels in the treatment of photoaging depends upon individual patient values and preferences.</p><p>Peels are classified by their intended depth of injury or ablation  (<a class="graphic graphic_table graphicRef75958" href="/z/d/graphic/75958.html" rel="external">table 6</a>). Chemical peels result in a thinner, more compact stratum corneum, thicker epidermis, and uniform distribution of melanin [<a href="#rid94">94</a>]. Superficial and medium-depth peels may improve mild or moderate photoaging. Deep peels may be used for severe photodamage. Adverse effects are more common with medium-depth and deep peels and include hypo- or hyperpigmentation, infection, and scarring. (See  <a class="medical medical_review" href="/z/d/html/13632.html" rel="external">"Chemical peels: Procedures and complications"</a>.)</p><p class="headingAnchor" id="H1838810232"><span class="h3">Topical fluorouracil</span><span class="headingEndMark"> — </span>Photoaging in patients with actinic keratoses may improve in response to treatment with topical <a class="drug drug_general" data-topicid="8464" href="/z/d/drug information/8464.html" rel="external">fluorouracil</a> [<a href="#rid95">95</a>]. Fluorouracil's mechanism of action involves epidermal injury, wound healing, and remodeling of the dermal matrix, resulting in improved appearance. (See  <a class="medical medical_review" href="/z/d/html/5336.html" rel="external">"Treatment of actinic keratosis", section on 'Topical fluorouracil'</a>.)</p><p>A beneficial effect of <a class="drug drug_general" data-topicid="8464" href="/z/d/drug information/8464.html" rel="external">fluorouracil</a> on the clinical signs of photoaging has been noted in several observational studies [<a href="#rid95">95,96</a>]. In one study, 21 patients aged 56 to 85 years who had multiple facial actinic keratoses and moderate to severe photoaging were treated with fluorouracil 5% for two weeks [<a href="#rid95">95</a>]. In addition to the expected clearance of actinic keratoses, improving of wrinkling, tactile roughness, lentigines, hyperpigmentation, and sallowness was noted starting four to six weeks after the completion of treatment and continuing through week 24.</p><p>However, a secondary analysis of data from a randomized trial including 932 veterans treated with a standard course of topical <a class="drug drug_general" data-topicid="8464" href="/z/d/drug information/8464.html" rel="external">fluorouracil</a> for the chemoprevention of basal and squamous cell carcinoma of the skin did not find a difference in photodamage (measured with four photonumeric scales) between baseline and 6, 12, and 18 months post-treatment [<a href="#rid97">97</a>].</p><p class="headingAnchor" id="H4066975148"><span class="h3">Photodynamic photorejuvenation</span><span class="headingEndMark"> — </span>Multiple studies have reported improvement in fine wrinkles, mottled hyperpigmentation, roughness, and sallowness following photodynamic therapy (PDT), a common treatment modality for actinic keratosis and field cancerization [<a href="#rid98">98-101</a>]. The mechanism of PDT in correcting the photodamage may include the upregulation of collagen production and increased epidermal proliferation [<a href="#rid102">102</a>].</p><p>PDT can be used alone or in combination with other treatment modalities for photoaging [<a href="#rid103">103</a>]. Pain during illumination is the main side effect of PDT. Daylight PDT, which is associated with little or no pain, may be an alternative and better accepted treatment modality [<a href="#rid104">104</a>]. (See  <a class="medical medical_review" href="/z/d/html/13647.html" rel="external">"Photodynamic therapy"</a>.)</p><p class="headingAnchor" id="H1104917722"><span class="h3">Invasive treatments</span><span class="headingEndMark"> — </span>Other treatments that are commonly used to improve the signs of photoaging include:</p><p class="bulletIndent1"><span class="glyph">●</span>Injectable botulinum toxin (see  <a class="medical medical_review" href="/z/d/html/13643.html" rel="external">"Overview of botulinum toxin for cosmetic indications"</a> and  <a class="medical medical_review" href="/z/d/html/16222.html" rel="external">"Botulinum toxin for cosmetic indications: Treatment of specific sites"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Injectable soft tissue fillers (see  <a class="medical medical_review" href="/z/d/html/16532.html" rel="external">"Injectable soft tissue fillers: Overview of clinical use"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laser resurfacing (see  <a class="medical medical_review" href="/z/d/html/13629.html" rel="external">"Ablative laser resurfacing for skin rejuvenation"</a> and  <a class="medical medical_review" href="/z/d/html/13645.html" rel="external">"Nonablative skin resurfacing for skin rejuvenation"</a>)</p><p></p><p class="headingAnchor" id="H16665067"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors and pathogenesis</strong> – Photoaging is premature skin aging that is responsible for most of the age-associated changes of the skin, especially in individuals with a history of prolonged and repeated exposure to solar radiation and in those with fair and less pigmented skin. Photoaging results from the loss of the structural integrity of the dermal extracellular matrix. While ultraviolet (UV) radiation, and in particular ultraviolet A (UVA) radiation, has a major pathogenetic role, wavelengths beyond the UV spectrum (infrared and visible light) also contribute to skin damage. (See <a class="local">'Epidemiology and risk factors'</a> above and <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Clinical signs of photoaging include wrinkles, lentigines, mottled hyperpigmentation, actinic keratoses, loss of translucency and elasticity, xerotic texture, and sallow color  (<a class="graphic graphic_picture graphicRef81287 graphicRef61033 graphicRef68136 graphicRef71483 graphicRef53576 graphicRef66252" href="/z/d/graphic/81287.html" rel="external">picture 2A-F</a>). (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sun protection</strong> – Protection from the sun, including sun avoidance and use of sunscreens and protective clothing, is the first line of defense against photoaging. We suggest regular use of broad-spectrum sunscreens, which provide protection against ultraviolet A (UVA) and ultraviolet B (UVB) radiation  (<a class="graphic graphic_table graphicRef73127" href="/z/d/graphic/73127.html" rel="external">table 3</a>), for patients who desire to prevent premature aging of the skin (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). Sunscreen use is advisable for individuals with all skin types and especially for those with light complexion (phototypes I, II, and III) who live in areas with high levels of solar irradiation. (See <a class="local">'Photoprotection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Topical retinoids</strong> – We suggest topical retinoids  (<a class="graphic graphic_table graphicRef70303" href="/z/d/graphic/70303.html" rel="external">table 5</a>) as the first-line therapy for patients who desire treatment for photoaging (<a class="grade" href="https:///uptodate/show/grade_4" rel="external">Grade 2A</a>). We prefer <a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">topical tretinoin</a> to other retinoids because it is the most extensively studied agent, is available in multiple concentrations, and is thus easier to titrate. Topical tretinoin can be used for mild to severe photoaging in patients of all skin prototypes. Topical tretinoin 0.02% or 0.025% cream or gel applied every other day, preferably at nighttime, is a common starting regimen. Tretinoin concentration and frequency of application may be gradually increased over several weeks as tolerated, up to a daily application of tretinoin 0.1%. (See <a class="local">'Tretinoin'</a> above.)</p><p></p><p class="bulletIndent2">Skin irritation, redness, and peeling are common adverse effects of <a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">topical tretinoin</a> and may be managed by dose titration and regular use of moisturizers. (See <a class="local">'Pretreatment counseling'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complementary therapies</strong> – Moisturizers containing cosmeceuticals, such as antioxidants, vitamins, or plant extracts, can be used in conjunction with topical retinoids for the treatment of photoaging  (<a class="graphic graphic_table graphicRef83291" href="/z/d/graphic/83291.html" rel="external">table 4</a>). However, there is limited evidence of efficacy from clinical studies to suggest these preparations. (See <a class="local">'Cosmeceuticals'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Procedural therapies</strong> – Procedural therapies used to improve the signs of photoaging, including chemical peels, injectable botulinum toxin, injectable soft tissue fillers, and laser resurfacing, are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/13643.html" rel="external">"Overview of botulinum toxin for cosmetic indications"</a> and  <a class="medical medical_review" href="/z/d/html/16532.html" rel="external">"Injectable soft tissue fillers: Overview of clinical use"</a> and  <a class="medical medical_review" href="/z/d/html/13629.html" rel="external">"Ablative laser resurfacing for skin rejuvenation"</a> and  <a class="medical medical_review" href="/z/d/html/13645.html" rel="external">"Nonablative skin resurfacing for skin rejuvenation"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gilchrest BA. Photoaging. J Invest Dermatol 2013; 133:E2.</a></li><li><a class="nounderline abstract_t">Maddin S, Lauharanta J, Agache P, et al. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J Am Acad Dermatol 2000; 42:56.</a></li><li><a class="nounderline abstract_t">Green AC, Hughes MC, McBride P, Fourtanier A. Factors associated with premature skin aging (photoaging) before the age of 55: a population-based study. Dermatology 2011; 222:74.</a></li><li><a class="nounderline abstract_t">Green AC. Premature ageing of the skin in a Queensland population. Med J Aust 1991; 155:473.</a></li><li><a class="nounderline abstract_t">Goh SH. The treatment of visible signs of senescence: the Asian experience. Br J Dermatol 1990; 122 Suppl 35:105.</a></li><li><a class="nounderline abstract_t">Nouveau-Richard S, Yang Z, Mac-Mary S, et al. Skin ageing: a comparison between Chinese and European populations. A pilot study. J Dermatol Sci 2005; 40:187.</a></li><li><a class="nounderline abstract_t">Talwar HS, Griffiths CE, Fisher GJ, et al. Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol 1995; 105:285.</a></li><li><a class="nounderline abstract_t">Panich U, Sittithumcharee G, Rathviboon N, Jirawatnotai S. Ultraviolet Radiation-Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging. Stem Cells Int 2016; 2016:7370642.</a></li><li><a class="nounderline abstract_t">Yaar M, Gilchrest BA. Photoageing: mechanism, prevention and therapy. Br J Dermatol 2007; 157:874.</a></li><li><a class="nounderline abstract_t">Benjamin CL, Ullrich SE, Kripke ML, Ananthaswamy HN. p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol 2008; 84:55.</a></li><li><a class="nounderline abstract_t">Schwarz T. 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol 2008; 84:10.</a></li><li><a class="nounderline abstract_t">Krutmann J, Morita A, Chung JH. Sun exposure: what molecular photodermatology tells us about its good and bad sides. J Invest Dermatol 2012; 132:976.</a></li><li><a class="nounderline abstract_t">Schroeder P, Lademann J, Darvin ME, et al. Infrared radiation-induced matrix metalloproteinase in human skin: implications for protection. J Invest Dermatol 2008; 128:2491.</a></li><li><a class="nounderline abstract_t">Schroeder P, Haendeler J, Krutmann J. The role of near infrared radiation in photoaging of the skin. Exp Gerontol 2008; 43:629.</a></li><li><a class="nounderline abstract_t">Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138:1462.</a></li><li><a class="nounderline abstract_t">Quan T, He T, Voorhees JJ, Fisher GJ. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J Biol Chem 2001; 276:26349.</a></li><li><a class="nounderline abstract_t">Fisher GJ, Voorhees JJ. Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc 1998; 3:61.</a></li><li><a class="nounderline abstract_t">Fisher GJ, Datta S, Wang Z, et al. c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest 2000; 106:663.</a></li><li><a class="nounderline abstract_t">Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463.</a></li><li><a class="nounderline abstract_t">Angel P, Szabowski A, Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 2001; 20:2413.</a></li><li><a class="nounderline abstract_t">Massagué J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000; 1:169.</a></li><li><a class="nounderline abstract_t">Senftleben U, Karin M. The IKK/NF-kappaB pathway. Crit Care Med 2002; 30:S18.</a></li><li><a class="nounderline abstract_t">Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107:135.</a></li><li><a class="nounderline abstract_t">Shen L, Fang H, Chen T, et al. Evaluating mitochondrial DNA in cancer occurrence and development. Ann N Y Acad Sci 2010; 1201:26.</a></li><li><a class="nounderline abstract_t">Park CB, Larsson NG. Mitochondrial DNA mutations in disease and aging. J Cell Biol 2011; 193:809.</a></li><li><a class="nounderline abstract_t">Berneburg M, Plettenberg H, Medve-König K, et al. Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. J Invest Dermatol 2004; 122:1277.</a></li><li><a class="nounderline abstract_t">Berneburg M, Gattermann N, Stege H, et al. Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem Photobiol 1997; 66:271.</a></li><li><a class="nounderline abstract_t">Vandiver AR, Irizarry RA, Hansen KD, et al. Age and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skin. Genome Biol 2015; 16:80.</a></li><li><a class="nounderline abstract_t">McDaniel D, Farris P, Valacchi G. Atmospheric skin aging-Contributors and inhibitors. J Cosmet Dermatol 2018; 17:124.</a></li><li><a class="nounderline abstract_t">Liebel F, Kaur S, Ruvolo E, et al. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. J Invest Dermatol 2012; 132:1901.</a></li><li class="breakAll">Lim H, Kang S, Chien AL. Photodamage in skin of color. In: Cutaneous Photoaging: Comprehensive Series in Photochemical and Photobiological Sciences, Watson RE, Griffiths CE (Eds), Royal Society of Chemistry, 2019. Vol 19, p.31.</li><li><a class="nounderline abstract_t">Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol 2010; 130:2092.</a></li><li><a class="nounderline abstract_t">Regazzetti C, Sormani L, Debayle D, et al. Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3. J Invest Dermatol 2018; 138:171.</a></li><li><a class="nounderline abstract_t">Krutmann J, Bouloc A, Sore G, et al. The skin aging exposome. J Dermatol Sci 2017; 85:152.</a></li><li><a class="nounderline abstract_t">Kim KE, Cho D, Park HJ. Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases. Life Sci 2016; 152:126.</a></li><li><a class="nounderline abstract_t">Li M, Vierkötter A, Schikowski T, et al. Epidemiological evidence that indoor air pollution from cooking with solid fuels accelerates skin aging in Chinese women. J Dermatol Sci 2015; 79:148.</a></li><li><a class="nounderline abstract_t">Krutmann J, Liu W, Li L, et al. Pollution and skin: from epidemiological and mechanistic studies to clinical implications. J Dermatol Sci 2014; 76:163.</a></li><li><a class="nounderline abstract_t">Vierkötter A, Krutmann J. Environmental influences on skin aging and ethnic-specific manifestations. Dermatoendocrinol 2012; 4:227.</a></li><li><a class="nounderline abstract_t">Lanuti EL, Kirsner RS. Effects of pollution on skin aging. J Invest Dermatol 2010; 130:2696.</a></li><li><a class="nounderline abstract_t">Vierkötter A, Schikowski T, Ranft U, et al. Airborne particle exposure and extrinsic skin aging. J Invest Dermatol 2010; 130:2719.</a></li><li><a class="nounderline abstract_t">Afaq F, Zaid MA, Pelle E, et al. Aryl hydrocarbon receptor is an ozone sensor in human skin. J Invest Dermatol 2009; 129:2396.</a></li><li><a class="nounderline abstract_t">Just M, Ribera M, Monsó E, et al. Effect of smoking on skin elastic fibres: morphometric and immunohistochemical analysis. Br J Dermatol 2007; 156:85.</a></li><li><a class="nounderline abstract_t">Model D. Smoker's face: an underrated clinical sign? Br Med J (Clin Res Ed) 1985; 291:1760.</a></li><li><a class="nounderline abstract_t">Daniell HW. Smoker's wrinkles. A study in the epidemiology of "crow's feet". Ann Intern Med 1971; 75:873.</a></li><li><a class="nounderline abstract_t">Morita A, Torii K, Maeda A, Yamaguchi Y. Molecular basis of tobacco smoke-induced premature skin aging. J Investig Dermatol Symp Proc 2009; 14:53.</a></li><li><a class="nounderline abstract_t">Malvy Jm, Guinot C, Preziosi P, et al. Epidemiologic determinants of skin photoaging: baseline data of the SU.VI.MAX. cohort. J Am Acad Dermatol 2000; 42:47.</a></li><li><a class="nounderline abstract_t">Kang S, Fisher GJ, Voorhees JJ. Photoaging and topical tretinoin: therapy, pathogenesis, and prevention. Arch Dermatol 1997; 133:1280.</a></li><li><a class="nounderline abstract_t">Kligman AM. Early destructive effect of sunlight on human skin. JAMA 1969; 210:2377.</a></li><li><a class="nounderline abstract_t">Griffiths CE, Goldfarb MT, Finkel LJ, et al. Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial. J Am Acad Dermatol 1994; 30:76.</a></li><li><a class="nounderline abstract_t">Vierkötter A, Hüls A, Yamamoto A, et al. Extrinsic skin ageing in German, Chinese and Japanese women manifests differently in all three groups depending on ethnic background, age and anatomical site. J Dermatol Sci 2016; 83:219.</a></li><li><a class="nounderline abstract_t">Paganelli A, Mandel VD, Kaleci S, et al. Favre-Racouchot disease: systematic review and possible therapeutic strategies. J Eur Acad Dermatol Venereol 2019; 33:32.</a></li><li><a class="nounderline abstract_t">Davis EC, Callender VD. Aesthetic dermatology for aging ethnic skin. Dermatol Surg 2011; 37:901.</a></li><li><a class="nounderline abstract_t">Chien AL, Qi J, Grandhi R, et al. Effect of Age, Gender, and Sun Exposure on Ethnic Skin Photoaging: Evidence Gathered Using a New Photonumeric Scale. J Natl Med Assoc 2018; 110:176.</a></li><li><a class="nounderline abstract_t">Griffiths CE, Wang TS, Hamilton TA, et al. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol 1992; 128:347.</a></li><li><a class="nounderline abstract_t">Chung JH. Photoaging in Asians. Photodermatol Photoimmunol Photomed 2003; 19:109.</a></li><li><a class="nounderline abstract_t">Chien AL, Qi J, Grandhi R, et al. Photoaging in african-american skin: a reliable photonumeric scale reveals age, male gender, and sun exposure as contributory factors. J Invest Dermatol 2015; 135:s28.</a></li><li><a class="nounderline abstract_t">Baillie L, Askew D, Douglas N, Soyer HP. Strategies for assessing the degree of photodamage to skin: a systematic review of the literature. Br J Dermatol 2011; 165:735.</a></li><li><a class="nounderline abstract_t">Rigel DS, Taylor SC, Lim HW, et al. Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel. J Am Acad Dermatol 2022; 86:S1.</a></li><li><a class="nounderline abstract_t">Wang SQ, Balagula Y, Osterwalder U. Photoprotection: a review of the current and future technologies. Dermatol Ther 2010; 23:31.</a></li><li><a class="nounderline abstract_t">Rigel DS, Rigel EG, Rigel AC. Effects of altitude and latitude on ambient UVB radiation. J Am Acad Dermatol 1999; 40:114.</a></li><li><a class="nounderline abstract_t">Kromann N, Wulf HC, Eriksen P, Brodthagen H. Relative ultraviolet spectral intensity of direct solar radiation, sky radiation and surface reflections. Relative contribution of natural sources to the outdoor UV irradiation of man. Photodermatol 1986; 3:73.</a></li><li><a class="nounderline abstract_t">Moise AF, Aynsley R. Ambient ultraviolet radiation levels in public shade settings. Int J Biometeorol 1999; 43:128.</a></li><li><a class="nounderline abstract_t">Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med 2013; 158:781.</a></li><li><a class="nounderline abstract_t">Randhawa M, Wang S, Leyden JJ, et al. Daily Use of a Facial Broad Spectrum Sunscreen Over One-Year Significantly Improves Clinical Evaluation of Photoaging. Dermatol Surg 2016; 42:1354.</a></li><li><a class="nounderline abstract_t">Hatch KL, Osterwalder U. Garments as solar ultraviolet radiation screening materials. Dermatol Clin 2006; 24:85.</a></li><li><a class="nounderline abstract_t">Wang SQ, Kopf AW, Marx J, et al. Reduction of ultraviolet transmission through cotton T-shirt fabrics with low ultraviolet protection by various laundering methods and dyeing: clinical implications. J Am Acad Dermatol 2001; 44:767.</a></li><li><a class="nounderline abstract_t">Davis S, Capjack L, Kerr N, Fedosejevs R. Clothing as protection from ultraviolet radiation: which fabric is most effective? Int J Dermatol 1997; 36:374.</a></li><li><a class="nounderline abstract_t">Crews PC, Kachman S, Beter AG. Influences on UVR transmission of undyed woven fabrics. Textile Chemist Colorist 1999; 31:17.</a></li><li><a class="nounderline abstract_t">Georgouras KE, Stanford DG, Pailthorpe MT. Sun protective clothing in Australia and the Australian/New Zealand standard: an overview. Australas J Dermatol 1997; 38 Suppl 1:S79.</a></li><li><a class="nounderline abstract_t">Taylor SC, Alexis AF, Armstrong AW, et al. Misconceptions of photoprotection in skin of color. J Am Acad Dermatol 2022; 86:S9.</a></li><li><a class="nounderline abstract_t">Pourciau CY, Eide MJ, Mahan M, Lim HW. Photoprotection counseling of non-white ethno-racial groups: a survey of the practice of expert dermatologists. Photodermatol Photoimmunol Photomed 2012; 28:335.</a></li><li><a class="nounderline abstract_t">Pichon LC, Corral I, Landrine H, et al. Sun-protection behaviors among African Americans. Am J Prev Med 2010; 38:288.</a></li><li><a class="nounderline abstract_t">Linos E, Keiser E, Kanzler M, et al. Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006. Cancer Causes Control 2012; 23:133.</a></li><li><a class="nounderline abstract_t">Marks R, Foley PA, Jolley D, et al. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch Dermatol 1995; 131:415.</a></li><li><a class="nounderline abstract_t">Lim HW, Gilchrest BA, Cooper KD, et al. Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol 2005; 52:868.</a></li><li><a class="nounderline abstract_t">Zussman J, Ahdout J, Kim J. Vitamins and photoaging: do scientific data support their use? J Am Acad Dermatol 2010; 63:507.</a></li><li><a class="nounderline abstract_t">Cho S, Lowe L, Hamilton TA, et al. Long-term treatment of photoaged human skin with topical retinoic acid improves epidermal cell atypia and thickens the collagen band in papillary dermis. J Am Acad Dermatol 2005; 53:769.</a></li><li><a class="nounderline abstract_t">Griffiths CE, Russman AN, Majmudar G, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 1993; 329:530.</a></li><li><a class="nounderline abstract_t">Bhawan J, Olsen E, Lufrano L, et al. Histologic evaluation of the long term effects of tretinoin on photodamaged skin. J Dermatol Sci 1996; 11:177.</a></li><li><a class="nounderline abstract_t">Kang S, Duell EA, Fisher GJ, et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol 1995; 105:549.</a></li><li><a class="nounderline abstract_t">Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379:335.</a></li><li><a class="nounderline abstract_t">Han A, Chien AL, Kang S. Photoaging. Dermatol Clin 2014; 32:291.</a></li><li><a class="nounderline abstract_t">Samuel M, Brooke RC, Hollis S, Griffiths CE. Interventions for photodamaged skin. Cochrane Database Syst Rev 2005; :CD001782.</a></li><li><a class="nounderline abstract_t">Loureiro KD, Kao KK, Jones KL, et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A 2005; 136:117.</a></li><li><a class="nounderline abstract_t">Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet 1997; 350:1143.</a></li><li><a class="nounderline abstract_t">Kang S, Leyden JJ, Lowe NJ, et al. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol 2001; 137:1597.</a></li><li><a class="nounderline abstract_t">Griffiths CE, Kang S, Ellis CN, et al. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. Arch Dermatol 1995; 131:1037.</a></li><li><a class="nounderline abstract_t">Kang S, Bergfeld W, Gottlieb AB, et al. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. Am J Clin Dermatol 2005; 6:245.</a></li><li><a class="nounderline abstract_t">Kang S, Krueger GG, Tanghetti EA, et al. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage. J Am Acad Dermatol 2005; 52:268.</a></li><li><a class="nounderline abstract_t">Kang S, Goldfarb MT, Weiss JS, et al. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial. J Am Acad Dermatol 2003; 49:83.</a></li><li><a class="nounderline abstract_t">Herane MI, Orlandi C, Zegpi E, et al. Clinical efficacy of adapalene (differin(®)) 0.3% gel in Chilean women with cutaneous photoaging. J Dermatolog Treat 2012; 23:57.</a></li><li class="breakAll">Kligman AM. Introduction: What is cosmeceuticals. In: Procedures in Cosmetic Dermatology Series: Cosmeceuticals, 1st ed, Draelos ZD (Ed), WB Saunders, Philadelphia 2005.</li><li><a class="nounderline abstract_t">Chien A, Cheng N, Shin J, et al. Topical retinol, a precursor to tretinoin, can deliver comparable efficacy to tretinoin in treatment. J Invest Dermatol 2012; 132, S1:S93.</a></li><li><a class="nounderline abstract_t">Fabbrocini G, De Padova MP, Tosti A. Chemical peels: what's new and what isn't new but still works well. Facial Plast Surg 2009; 25:329.</a></li><li><a class="nounderline abstract_t">Sachs DL, Kang S, Hammerberg C, et al. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis. Arch Dermatol 2009; 145:659.</a></li><li><a class="nounderline abstract_t">Guimarães CO, Miot HA, Bagatin E. Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study. Dermatol Surg 2014; 40:610.</a></li><li><a class="nounderline abstract_t">Korgavkar K, Lee KC, Weinstock MA, Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group. Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial. JAMA Dermatol 2017; 153:1142.</a></li><li><a class="nounderline abstract_t">Kohl E, Torezan LA, Landthaler M, Szeimies RM. Aesthetic effects of topical photodynamic therapy. J Eur Acad Dermatol Venereol 2010; 24:1261.</a></li><li><a class="nounderline abstract_t">Sanclemente G, Medina L, Villa JF, et al. A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage. J Eur Acad Dermatol Venereol 2011; 25:49.</a></li><li><a class="nounderline abstract_t">Le Pillouer-Prost A, Cartier H. Photodynamic Photorejuvenation: A Review. Dermatol Surg 2016; 42:21.</a></li><li><a class="nounderline abstract_t">Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol 2013; 27:672.</a></li><li><a class="nounderline abstract_t">Fonda-Pascual P, Moreno-Arrones OM, Alegre-Sanchez A, et al. In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology. Methods 2016; 109:190.</a></li><li><a class="nounderline abstract_t">Szeimies RM, Lischner S, Philipp-Dormston W, et al. Photodynamic therapy for skin rejuvenation: treatment options - results of a consensus conference of an expert group for aesthetic photodynamic therapy. J Dtsch Dermatol Ges 2013; 11:632.</a></li><li><a class="nounderline abstract_t">Lane KL, Hovenic W, Ball K, Zachary CB. Daylight photodynamic therapy: the Southern California experience. Lasers Surg Med 2015; 47:168.</a></li></ol></div><div id="topicVersionRevision">Topic 15255 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23820721" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Photoaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10607320" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21196710" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Factors associated with premature skin aging (photoaging) before the age of 55: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1921818" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Premature ageing of the skin in a Queensland population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2337528" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The treatment of visible signs of senescence: the Asian experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16154324" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Skin ageing: a comparison between Chinese and European populations. A pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7543550" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Reduced type I and type III procollagens in photodamaged adult human skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27148370" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Ultraviolet Radiation-Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17711532" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Photoageing: mechanism, prevention and therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18173701" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18173696" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22170486" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sun exposure: what molecular photodermatology tells us about its good and bad sides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18449210" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Infrared radiation-induced matrix metalloproteinase in human skin: implications for protection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18534799" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The role of near infrared radiation in photoaging of the skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12437452" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Mechanisms of photoaging and chronological skin aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11320083" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9732061" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10974019" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11687497" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : How matrix metalloproteinases regulate cell behavior.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11402337" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Function and regulation of AP-1 subunits in skin physiology and pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11252892" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : How cells read TGF-beta signals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11891403" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The IKK/NF-kappaB pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11160126" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20649535" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Evaluating mitochondrial DNA in cancer occurrence and development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21606204" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Mitochondrial DNA mutations in disease and aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15140232" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9277148" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25886480" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Age and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29575554" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Atmospheric skin aging-Contributors and inhibitors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22318388" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22318388" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20410914" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Impact of long-wavelength UVA and visible light on melanocompetent skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28842328" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27720464" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The skin aging exposome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27018067" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26055797" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Epidemiological evidence that indoor air pollution from cooking with solid fuels accelerates skin aging in Chinese women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25278222" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Pollution and skin: from epidemiological and mechanistic studies to clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23467702" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Environmental influences on skin aging and ethnic-specific manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21068731" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effects of pollution on skin aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664556" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Airborne particle exposure and extrinsic skin aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19536146" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Aryl hydrocarbon receptor is an ozone sensor in human skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17199572" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Effect of smoking on skin elastic fibres: morphometric and immunohistochemical analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3936573" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Smoker's face: an underrated clinical sign?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5134897" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Smoker's wrinkles. A study in the epidemiology of "crow's feet".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19675554" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Molecular basis of tobacco smoke-induced premature skin aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10607319" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Epidemiologic determinants of skin photoaging: baseline data of the SU.VI.MAX. cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9382567" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Photoaging and topical tretinoin: therapy, pathogenesis, and prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5395389" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Early destructive effect of sunlight on human skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8277035" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27289339" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Extrinsic skin ageing in German, Chinese and Japanese women manifests differently in all three groups depending on ethnic background, age and anatomical site.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30022555" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Favre-Racouchot disease: systematic review and possible therapeutic strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21585594" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Aesthetic dermatology for aging ethnic skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29580452" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Effect of Age, Gender, and Sun Exposure on Ethnic Skin Photoaging: Evidence Gathered Using a New Photonumeric Scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1550366" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A photonumeric scale for the assessment of cutaneous photodamage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12914595" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Photoaging in Asians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Photoaging in african-american skin: a reliable photonumeric scale reveals age, male gender, and sun exposure as contributory factors</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21574981" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Strategies for assessing the degree of photodamage to skin: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34942296" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20136907" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Photoprotection: a review of the current and future technologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9922027" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Effects of altitude and latitude on ambient UVB radiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3703716" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Relative ultraviolet spectral intensity of direct solar radiation, sky radiation and surface reflections. Relative contribution of natural sources to the outdoor UV irradiation of man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10639905" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Ambient ultraviolet radiation levels in public shade settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23732711" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Sunscreen and prevention of skin aging: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27749441" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Daily Use of a Facial Broad Spectrum Sunscreen Over One-Year Significantly Improves Clinical Evaluation of Photoaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16311171" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Garments as solar ultraviolet radiation screening materials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11312422" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Reduction of ultraviolet transmission through cotton T-shirt fabrics with low ultraviolet protection by various laundering methods and dyeing: clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9199990" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Clothing as protection from ultraviolet radiation: which fabric is most effective?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Influences on UVR transmission of undyed woven fabrics</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10994479" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Sun protective clothing in Australia and the Australian/New Zealand standard: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34942293" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Misconceptions of photoprotection in skin of color.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23126297" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Photoprotection counseling of non-white ethno-racial groups: a survey of the practice of expert dermatologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20171530" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Sun-protection behaviors among African Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22045154" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7726582" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15858480" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Sunlight, tanning booths, and vitamin D.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20189681" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Vitamins and photoaging: do scientific data support their use?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16243124" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Long-term treatment of photoaged human skin with topical retinoic acid improves epidermal cell atypia and thickens the collagen band in papillary dermis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8336752" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8785167" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Histologic evaluation of the long term effects of tretinoin on photodamaged skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7561157" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8552187" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Molecular basis of sun-induced premature skin ageing and retinoid antagonism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24891052" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Photoaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15674885" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Interventions for photodamaged skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15940677" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9343507" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Safety of first-trimester exposure to topical tretinoin: prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11735710" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7544967" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16060712" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15692472" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12833014" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22007702" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Clinical efficacy of adapalene (differin(®)) 0.3% gel in Chilean women with cutaneous photoaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22007702" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Clinical efficacy of adapalene (differin(®)) 0.3% gel in Chilean women with cutaneous photoaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Topical retinol, a precursor to tretinoin, can deliver comparable efficacy to tretinoin in treatment</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20024875" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Chemical peels: what's new and what isn't new but still works well.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19528421" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24852464" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28877312" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20236377" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Aesthetic effects of topical photodynamic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20456545" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26713598" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Photodynamic Photorejuvenation: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23181556" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27422482" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23650971" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Photodynamic therapy for skin rejuvenation: treatment options - results of a consensus conference of an expert group for aesthetic photodynamic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25663047" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Daylight photodynamic therapy: the Southern California experience.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
